Lineage Cell Therapeutics

Lineage Cell Therapeutics, founded in the United States, is a biotechnology company dedicated to pioneering a new branch of medicine through cell-based therapies and gene marker-based molecular diagnostics. The company's core mission is to develop and deliver innovative treatments for degenerative conditions by transplanting specific cell types to patients with serious medical conditions. Lineage's product pipeline includes therapies targeting eye diseases, among other degenerative conditions, with a focus on improving patient outcomes through advanced biotechnological solutions.

Notable affiliations include a collaboration with Genentech to develop allogeneic retinal pigment epithelial (RPE) cells for treating eye diseases. Key achievements for Lineage Cell Therapeutics include advancing their cell therapy pipeline and establishing significant partnerships within the biotech industry. The company's impact lies in its potential to revolutionize treatment paradigms for degenerative diseases, offering hope and improved quality of life for patients suffering from these conditions.